Porcine Epidemic Diarrhea (PED)

Porcine Epidemic Diarrhea is a highly contagious viral disease of swine caused by a coronavirus that attacks the intestinal epithelium, resulting in severe diarrhea, vomiting, dehydration, and high mortality, particularly in young piglets. The disease emerged as a major threat to the global swine industry following its introduction to previously naive populations, where it caused devastating outbreaks with near-total mortality in suckling piglets. PED represents one of the most economically significant swine diseases worldwide, with outbreaks capable of decimating pig populations on affected farms within days of introduction.

The disease affects swine populations across Asia, Europe, and the Americas, having spread globally through international trade and movement of contaminated materials. First identified in England in the early 1970s and subsequently in Asia where it became endemic, PED gained dramatic attention when it emerged in the United States in 2013, spreading rapidly across the country and causing unprecedented losses in a naive population. The virus continues to circulate in endemic regions with periodic epidemic waves in areas with waning herd immunity. All ages of pigs are susceptible to infection, but clinical severity varies dramatically, with neonatal piglets experiencing mortality rates approaching 100 percent while older growing pigs and adults typically survive with temporary illness.

The economic impact of porcine epidemic diarrhea on affected operations is catastrophic during initial outbreaks and remains substantial even after the disease becomes endemic. Direct losses include high mortality in suckling piglets, with entire farrowing groups potentially lost during acute outbreaks. Reduced reproductive performance occurs as sow health is compromised and weaning weights plummet. Treatment costs, though largely supportive, accumulate rapidly during outbreak management. Biosecurity enhancements and depopulation-repopulation strategies for severely affected herds require major capital investment. The US outbreak was estimated to have killed millions of pigs in its first year, with industry losses in the billions of dollars, demonstrating the disease's potential for catastrophic economic impact.

There is no specific antiviral treatment for porcine epidemic diarrhea, making prevention through biosecurity and immunity development the primary management strategies. Supportive care including fluid and electrolyte replacement can reduce mortality in piglets but cannot eliminate it in very young animals. Vaccines have been developed and provide partial protection, though their efficacy varies depending on the vaccine type, timing, and challenge strain. Building herd immunity through controlled exposure or vaccination of breeding females provides colostral protection for piglets born to immune sows. Understanding PED epidemiology and implementing rigorous biosecurity are essential for protecting naive herds and managing endemic situations in previously exposed populations.

Porcine Epidemic Diarrhea is caused by Porcine Epidemic Diarrhea Virus, an enveloped single-stranded RNA virus belonging to the family Coronaviridae, genus Alphacoronavirus. The virus is closely related to other swine coronaviruses including Transmissible Gastroenteritis Virus but is antigenically distinct, meaning immunity to one does not protect against the other. Multiple strains of PEDV exist with varying virulence, including both classical strains that have circulated for decades in Asia and highly virulent strains responsible for the devastating North American outbreaks. The viral spike protein, which mediates cell entry, is a major target for immune responses and a key determinant of strain characteristics.

Genetic susceptibility to PEDV infection is not well-characterized in terms of breed-specific resistance, as all pigs appear fully susceptible to infection regardless of genetics. However, the outcome of infection is dramatically influenced by age and immune status, with neonatal piglets lacking maternal immunity experiencing near-universal mortality while older pigs and those with passive or active immunity typically survive. Some research suggests individual variation in disease severity that could have genetic components, but specific resistance genes have not been identified. The overwhelming importance of immune status and age means that genetic factors are overshadowed by these other determinants of disease outcome.

Environmental factors play crucial roles in PEDV transmission and outbreak dynamics. The virus is relatively resistant to environmental conditions and can survive for extended periods outside the host, particularly in cool, moist environments. Contaminated feces contain extremely high viral loads and serve as the primary source of environmental contamination. The virus can survive in contaminated trailers, equipment, and facilities for days to weeks, facilitating mechanical transmission. Cold weather appears to favor viral survival and may contribute to increased outbreak frequency during winter months. Poor sanitation and inadequate cleaning allow viral accumulation in facilities. The virus can persist in feed and feed ingredients, which have been implicated in long-distance transmission events.

Risk factors for PEDV infection and severe disease outcomes are well-characterized from outbreak investigations and experimental studies. Naive populations with no prior exposure or vaccination are at highest risk for explosive outbreaks with catastrophic mortality. Neonatal piglets less than seven days old face the highest mortality risk due to immature intestinal development and lack of passive immunity. Operations with frequent animal or vehicle movements and connections to multiple other farms have greater introduction risk. Facilities near other swine operations may face aerosol transmission, particularly during favorable weather conditions. Feed mills and delivery systems shared among farms create potential contamination networks. Personnel movement between farms without adequate biosecurity represents another significant risk pathway.

The pathophysiology of porcine epidemic diarrhea involves viral destruction of intestinal absorptive capacity leading to severe malabsorptive diarrhea. Following oral ingestion of contaminated material, the virus infects and destroys enterocytes, the absorptive epithelial cells lining the small intestinal villi. Villous atrophy results as infected cells die and slough, dramatically reducing the intestinal surface area available for nutrient and fluid absorption. In neonatal piglets, the immature intestinal epithelium has limited regenerative capacity, and the rapid enterocyte turnover needed for recovery cannot keep pace with viral destruction. The resulting malabsorption causes profuse watery diarrhea and rapid dehydration. Metabolic acidosis develops from bicarbonate loss, while hypoglycemia occurs due to inability to absorb nutrients. Death typically results from dehydration, electrolyte imbalances, and metabolic derangement rather than direct viral effects on other organs.

Early warning signs of porcine epidemic diarrhea may be subtle initially but progress rapidly to obvious clinical illness within hours of exposure in susceptible populations. The first indicator in breeding herds is often reduced appetite in lactating sows, followed quickly by onset of diarrhea in both sows and their litters. Affected sows may show mild lethargy and reduced milk production preceding more obvious signs. In nursery and finishing populations, the first signs typically include decreased feed consumption noticed at group level, followed by onset of diarrhea spreading rapidly through the population. The speed of spread is a characteristic feature, with an entire barn potentially showing signs within 2 to 3 days of initial introduction.

The hallmark clinical presentation of PEDV infection is acute onset of severe watery diarrhea affecting all ages of pigs but varying in severity by age. Neonatal piglets develop profuse, watery, yellowish diarrhea within hours of exposure, with rapid progression to severe dehydration. Vomiting frequently accompanies diarrhea and precedes it in some animals. Older pigs including growing pigs, finishing pigs, and breeding adults also develop watery diarrhea but generally show less severe clinical illness and lower mortality. The diarrhea has a distinctively foul odor and characteristic watery consistency that distinguishes it clinically from some other causes of swine enteritis. Sows may show anorexia and agalactia in addition to diarrhea.

Behavioral changes in PEDV-infected pigs reflect both intestinal distress and the systemic effects of dehydration and metabolic derangement. Neonatal piglets become progressively less active and cease nursing as disease progresses, huddling together and showing reduced response to stimuli. Older pigs demonstrate lethargy and depression, spending more time lying down and less time engaged in normal behaviors. Feed intake drops dramatically across all age groups. Affected animals show signs of abdominal discomfort including repeated attempts to defecate and stretching postures. Sows with severe illness may show poor mothering behavior and neglect their litters, compounding piglet mortality.

Physical examination findings in PEDV-infected pigs vary with disease duration and severity but consistently demonstrate evidence of dehydration and intestinal dysfunction. Neonatal piglets rapidly develop severe dehydration evidenced by sunken eyes, loss of skin elasticity, dry mucous membranes, and a gaunt, tucked appearance. Body temperature may be subnormal as metabolic capacity fails. Extremities become cold and cyanotic in terminal stages. Older pigs show milder dehydration with rough hair coat, mild weight loss, and fecal staining of the perineum. Abdominal palpation reveals fluid-filled intestines. Rectal temperature is often normal or slightly elevated in the early stages but may become subnormal in severely affected animals.

Symptom progression in neonatal piglets is devastatingly rapid, with death occurring within 24 to 72 hours of symptom onset in many cases. Initial mild depression and reduced nursing activity progress within hours to obvious diarrhea and vomiting. Dehydration develops rapidly as fluid losses exceed any intake, with piglets becoming progressively weaker and more depressed. Terminal piglets become recumbent, hypothermic, and unresponsive before death. In contrast, older pigs typically show a more protracted course over 5 to 7 days, with gradual improvement following the acute diarrhea phase if supportive care is adequate. Sows often recover appetite within 3 to 5 days, though milk production may be compromised, affecting surviving piglets.

Emergency symptoms requiring immediate attention include any clinical signs consistent with PEDV in a previously naive herd, where rapid implementation of biosecurity measures may limit spread. In individual animals, signs of severe dehydration including marked skin tenting, sunken eyes, recumbency, and hypothermia indicate critical illness requiring aggressive supportive care or humane euthanasia. High mortality in suckling piglets, particularly with the characteristic rapid spread pattern, demands urgent veterinary involvement for diagnosis and outbreak management. Because PEDV is a reportable disease in some jurisdictions, veterinary authorities may need to be notified, adding regulatory urgency to the response.

Clinical examination of pigs with suspected PEDV infection focuses on recognizing the characteristic syndrome of acute watery diarrhea with rapid spread through the population. The combination of explosive onset, near-simultaneous appearance across age groups, high mortality in suckling piglets, and distinctive watery diarrhea raises strong clinical suspicion for PEDV or similar coronaviral infection. Physical examination documents dehydration severity, body temperature, and overall clinical status. Importantly, clinical differentiation between PEDV and Transmissible Gastroenteritis Virus is essentially impossible without laboratory testing, as both produce virtually identical clinical pictures. The pattern of disease spread and mortality distribution provides epidemiological clues but cannot definitively establish diagnosis.

Laboratory diagnostic tests are essential for confirming PEDV infection and should be pursued promptly when the disease is suspected. Polymerase chain reaction testing of feces, intestinal contents, or environmental samples provides sensitive and specific detection of viral RNA and is the primary diagnostic method. Real-time RT-PCR allows quantification of viral load and rapid turnaround times. Sample collection should include feces from acutely affected, untreated animals, with intestinal contents from freshly dead piglets providing excellent diagnostic material. Immunohistochemistry on intestinal tissue sections demonstrates viral antigen in enterocytes and confirms active infection in examined tissues. Serology using ELISA detects antibodies to PEDV and is useful for herd-level surveillance and monitoring immunity status but has limited value for acute disease diagnosis due to the time required for antibody development.

Differential diagnosis of PEDV must consider other causes of severe acute diarrhea in swine, particularly other enteric viral infections. Transmissible gastroenteritis virus produces an identical clinical syndrome and can only be differentiated through laboratory testing. Porcine deltacoronavirus, another emerging swine coronavirus, causes similar clinical disease and must be ruled out. Rotavirus causes diarrhea primarily in young pigs but typically with lower mortality than PEDV. Colibacillosis produces neonatal diarrhea but usually has less explosive herd-wide spread. Clostridium perfringens type C causes severe hemorrhagic enteritis in neonatal piglets with somewhat different fecal characteristics. Given the similar presentations of these diseases and the importance of accurate diagnosis for management decisions, laboratory confirmation should always be obtained.

Herd-level diagnostics provide essential information for understanding outbreak scope and guiding management responses. Systematic sampling across age groups and production areas determines disease distribution within the operation. Environmental sampling of facilities, equipment, and potential contamination pathways helps identify transmission routes. Surveillance of breeding stock serological status monitors immunity development following exposure. Feed and feed ingredient testing may identify contamination sources in some outbreak investigations. Ongoing PCR monitoring of populations can detect viral persistence or re-introduction following initial outbreak resolution. Coordination with diagnostic laboratories and veterinary authorities ensures appropriate testing approaches and compliance with any reporting requirements.

Emergency treatment of PEDV-affected piglets focuses on supportive care to address dehydration and metabolic derangements, as no specific antiviral therapy exists. Oral electrolyte solutions provided to suckling piglets help replace fluid and electrolyte losses, with commercial products designed for neonatal pigs preferred over improvised solutions. Supplemental feeding with milk replacer may help piglets with reduced access to sow milk. Maintaining environmental temperature in the optimal range of 85 to 95 degrees Fahrenheit for neonatal piglets reduces metabolic demands and improves survival. Despite supportive care, mortality in young piglets during acute outbreaks typically remains extremely high due to the severity of intestinal damage in this age group.

Medical management of PEDV infection is limited by the lack of effective antiviral drugs for use in pigs. Antibiotics do not affect viral infection but may be used to prevent or treat secondary bacterial infections that can complicate recovery. Medications to reduce intestinal motility are generally contraindicated as they may prolong viral presence in the gut. Anti-inflammatory medications have limited role and may be counterproductive. The focus of management appropriately shifts from individual animal treatment to population-level strategies aimed at controlling spread, building immunity, and managing the outbreak at a herd level. This represents a fundamentally different approach than typical infectious disease treatment in which antimicrobial therapy targets the causative organism.

Surgical intervention has no role in PEDV treatment. The disease process involves diffuse intestinal pathology not amenable to surgical correction. Management is entirely medical and supportive, with emphasis on population-level strategies rather than individual animal interventions. Resources are typically more effectively directed toward biosecurity, facility management, and immunity building rather than intensive treatment of individual affected animals, particularly given the poor prognosis for neonatal piglets.

Supportive care for PEDV-affected pigs of all ages emphasizes maintaining hydration, providing optimal environmental conditions, and ensuring nutritional support. Water consumption should be encouraged and monitored, with electrolyte supplementation considered for severely affected groups. Feed may need to be adjusted to more digestible formulations during recovery. Temperature control is particularly important for young pigs with limited thermoregulatory capacity. Segregation of severely affected individuals allows more intensive care and reduces viral shedding exposure for less affected penmates. Sow nutrition and hydration support helps maintain milk production for surviving piglets.

Herd management protocols during PEDV outbreaks prioritize limiting spread, building population immunity, and preparing for recovery. Strict biosecurity measures attempt to prevent transmission to unaffected areas of the operation and to neighboring farms. Controlled exposure strategies, including feedback of infectious material to breeding females, may be used to build immunity and move toward stable endemic status more quickly than natural spread would allow. This approach, while counterintuitive, accelerates immunity development in breeding stock so that future litters receive protective colostral antibodies. Farrowing management during outbreaks may include moving up farrowing dates or fostering strategies to minimize piglet losses. Planning for increased breeding activity following outbreak resolution helps restore pig flow.

Management decisions during PEDV outbreaks must balance immediate losses against long-term herd health and economic sustainability. In naive herds, the decision between attempting containment versus controlled exposure to build herd immunity depends on operation structure, biosecurity capacity, and market conditions. Individual piglet treatment decisions weigh the very poor prognosis in young animals against the costs of intensive care. Breeding herd management focuses on maintaining sow health and building immunity while accepting temporary reproductive losses. Economic analysis helps guide decisions about depopulation and restocking versus continued operation through endemic transition. Veterinary guidance is essential for navigating these complex decisions.

Recovery timeline from PEDV infection varies dramatically by age group and individual animal factors. Surviving piglets that develop diarrhea in the first week of life face prolonged recovery periods, with intestinal repair and return to normal function requiring 2 to 4 weeks. Growth performance in surviving piglets is often permanently compromised, with these animals remaining smaller than unaffected contemporaries throughout the production cycle. Older growing and finishing pigs typically recover within 7 to 14 days, with diarrhea resolving and appetite returning, though temporary growth setbacks may persist. Breeding animals generally recover fully within 7 to 10 days, with reproductive performance returning to normal in subsequent cycles.

Post-outbreak care and monitoring focus on supporting recovery while managing the transition to endemic stability or elimination. Piglet survival rates should be tracked to assess recovery progress and identify any secondary problems. Growth performance monitoring in nursery and finishing groups quantifies outbreak impact and recovery trajectory. Sow reproductive parameters including subsequent farrowing rates, litter sizes, and weaning weights evaluate breeding herd recovery. Serological monitoring of breeding females tracks immunity development and maintenance. Ongoing environmental PCR testing detects viral persistence or re-introduction. Feed and water consumption data provide early indicators of any recurring health challenges.

Prognosis following PEDV exposure depends primarily on age and immune status at the time of infection. Neonatal piglets less than one week old in naive populations face near-universal mortality regardless of supportive care. Piglets born to immune sows have dramatically better survival rates due to passive antibody protection. Older growing pigs have favorable prognosis for survival but may experience lasting growth impacts. Breeding animals typically survive and recover reproductive function. Herd-level prognosis improves substantially once population immunity is established, with subsequent generations of piglets protected through colostral immunity from previously exposed sows.

Return to production following PEDV outbreaks requires attention to immunity maintenance and continued biosecurity vigilance. Breeding herds that have experienced PEDV develop population immunity that protects future litters, but this immunity may wane over time without re-exposure or vaccination, potentially creating vulnerability to future outbreaks. Marketing schedules may need adjustment to accommodate the pig flow disruptions caused by outbreak mortality. Replacement gilt sourcing requires consideration of immune status to maintain herd immunity. Documentation of outbreak impact and recovery helps inform future management decisions and provides baseline data for comparison. Some operations may choose elimination and restocking strategies rather than living with endemic PEDV, particularly if biosecurity can be enhanced to prevent re-introduction.

Vaccination against PEDV is a key component of prevention strategies, though vaccine effectiveness has been variable depending on product, administration protocol, and challenge conditions. Both killed and modified live vaccines are available in different markets, with varying efficacy reports. Vaccination of breeding females aims to stimulate production of antibodies that will be transferred to piglets through colostrum, providing passive protection during the vulnerable neonatal period. Vaccination protocols typically include initial immunization followed by boosters, with timing designed to maximize colostral antibody levels at farrowing. While vaccines reduce disease severity and piglet mortality, they may not prevent infection entirely, and breakthrough disease can occur.

Biosecurity measures represent the most important line of defense against PEDV introduction to naive herds. Strict control of farm entry for personnel, animals, and materials prevents introduction of contaminated items. Transportation biosecurity including trailer washing and disinfection, driver protocols, and pig handling procedures addresses a major transmission pathway. Loading and unloading areas should be designed to prevent contamination of clean areas. Personnel protocols including shower requirements, dedicated footwear and clothing, and downtime rules reduce human-mediated transmission risk. Feed and ingredient sourcing from suppliers with biosecurity programs and potential mitigation treatments reduces feed-borne introduction risk. Pest control eliminates wild animal vectors.

Feedback and controlled exposure strategies are used in some endemic situations to ensure breeding female immunity and protect subsequent litters. These approaches involve deliberate exposure of naive breeding stock to infected material from the farm, typically intestinal contents or feces from acutely infected piglets. The goal is to infect and immunize all breeding females so that all litters benefit from colostral antibody protection. While effective at building herd immunity, these approaches carry ethical considerations, animal welfare implications, and risks of perpetuating infection. They should only be implemented under veterinary guidance after careful consideration of alternatives including vaccination. Timing of feedback programs aims to complete immunization well before the next farrowing season to allow maximum antibody development.

Environmental management and sanitation reduce viral persistence and transmission risk. Thorough cleaning and disinfection between groups removes viral contamination from facilities. The virus is susceptible to many common disinfectants when applied correctly after adequate cleaning. Drying time following disinfection improves efficacy. Temperature management in facilities may influence viral survival. Pest exclusion prevents wild animal-mediated transmission. Manure management prevents accumulation of infectious material. Feed and water system sanitation reduces oral exposure routes. All-in-all-out production with cleaning between groups interrupts transmission cycles.

Surveillance and monitoring programs support both prevention and early detection of PEDV. Diagnostic testing of sick animals enables rapid identification of incursions. Serological monitoring of breeding populations tracks immunity status. Environmental sampling can detect viral contamination before clinical disease appears. Supply chain surveillance monitors feed ingredients and transport biosecurity. Regional disease monitoring provides early warning of outbreaks in neighboring areas. Participation in industry surveillance networks contributes to collective disease intelligence. Preparedness planning ensures rapid response capability if introduction occurs despite prevention efforts.

Daily management and monitoring practices in PEDV-endemic operations focus on detecting disease, supporting affected animals, and maintaining biosecurity to prevent spread. Daily observation rounds should include assessment of fecal consistency in all groups, with any increase in diarrhea prevalence triggering investigation. Piglet viability and nursing activity provide early indicators of sow health and milk quality. Feed and water consumption monitoring across the operation identifies groups with potential health challenges. Mortality recording by age group and location enables pattern recognition and rapid response to emerging problems. Temperature monitoring ensures environmental conditions support animal health and immune function.

Facility management for PEDV control emphasizes hygiene, environmental control, and transmission prevention. Farrowing facilities require scrupulous sanitation between litters, with adequate downtime for drying. Heating systems must maintain appropriate temperatures for neonatal piglets. Ventilation systems should minimize drafts while providing adequate air exchange. Nursery and finishing facilities benefit from all-in-all-out management with cleaning between groups. Feed delivery systems should be designed to prevent contamination. Loading and unloading areas require particular attention as high-risk contamination points. Equipment used across multiple areas requires sanitation protocols between uses.

Herd health programs in operations with PEDV history integrate viral disease management with other health priorities. Vaccination programs for breeding stock require scheduling that maintains immunity while coordinating with other vaccine administrations. Gilt development units serve as controlled environments for building immunity in replacement animals before main herd entry. Acclimation protocols ensure new animals develop immunity without threatening production areas. Health monitoring includes both clinical surveillance and periodic diagnostic testing. Record keeping tracks disease occurrence, vaccination compliance, and immunity status. Veterinary oversight ensures program optimization and rapid response to problems.

Record keeping and data management support PEDV control through tracking of disease occurrence, intervention effectiveness, and immunity status. Farrowing records should include preweaning mortality by litter and any clinical signs noted. Nursery and finisher mortality and health records identify patterns potentially related to PEDV. Vaccination records document breeding herd immunity maintenance. Diagnostic test results track viral detection and serological status. Biosecurity compliance records ensure protocols are followed. Production data analysis reveals disease impacts on growth performance and reproductive efficiency. Periodic program review uses accumulated data to refine prevention and management strategies.

Economic management of PEDV recognizes both the potential for catastrophic losses during outbreaks and the ongoing costs of prevention and endemic disease management. Biosecurity investments including facility modifications, personnel protocols, and supplier programs require evaluation against introduction risk. Vaccination costs must be weighed against expected disease reduction benefits. Production impacts from endemic disease, even when well-controlled, affect profitability calculations. Insurance products may be available for catastrophic disease losses. Economic modeling can help evaluate different management strategies including elimination and restocking approaches versus endemic management. The extremely high stakes of PEDV in naive populations justify substantial investment in prevention for operations that have avoided introduction.

No specific breed or genetic line of pigs has demonstrated significantly greater or lesser susceptibility to PEDV infection, with all commercial swine genetics appearing fully susceptible to the virus when naive. The near-universal susceptibility observed across diverse pig populations during the North American outbreak suggests minimal genetic resistance exists in current commercial genetics. Disease outcome is determined primarily by immune status, with animals possessing passive or active immunity experiencing dramatically reduced clinical severity compared to naive individuals. Age at infection represents the overwhelming determinant of mortality risk, dwarfing any potential genetic influences on disease outcome.

Production system characteristics influence PEDV risk and impact more than genetic factors. Large integrated operations with multiple connected sites face greater introduction risk and potential for rapid spread through the production network compared to isolated independent farms. Operations with high biosecurity standards and limited external connections have demonstrated ability to remain PEDV-free even during regional outbreaks. Breeding operations and multiplier farms face particular risk due to the movement of animals that characterizes these businesses. Market connections and transportation networks create exposure pathways regardless of on-farm genetics. The production system context fundamentally shapes disease risk and should drive management decisions.

Genetic approaches to PEDV resistance remain largely theoretical, as specific resistance genes have not been identified or incorporated into commercial breeding programs. Research has explored genetic variation in immune responses to PEDV, but practical applications have not emerged. The predominant importance of passive maternal immunity in protecting piglets means that breeding herd immunity status overshadows any genetic differences in individual susceptibility. As genomic tools advance, selection for general disease resistance and immune competence may provide indirect benefits for PEDV outcomes. Currently, management interventions including vaccination and biosecurity provide the primary means of PEDV control regardless of pig genetics. Producers should focus on these controllable factors rather than seeking genetic solutions that are not currently available.

Several enteric viral diseases produce clinical presentations similar to PEDV and may occur concurrently in swine populations. Transmissible gastroenteritis virus causes a syndrome essentially identical to PEDV, with acute onset watery diarrhea, vomiting, and high neonatal mortality. Differentiation requires laboratory testing, as clinical signs alone cannot distinguish these coronaviral infections. Porcine deltacoronavirus, a more recently emerged swine coronavirus, causes similar enteric disease and may co-circulate with PEDV on some farms. Rotavirus infection causes diarrhea in young pigs with generally lower severity than PEDV but may occur simultaneously or sequentially. These viruses share transmission routes and some management approaches apply across coronavirus infections.

Differential diagnosis of acute diarrheal disease in swine must consider bacterial as well as viral causes. Colibacillosis causes neonatal diarrhea that may resemble PEDV in individual animals, though the explosive herd-wide spread characteristic of PEDV helps distinguish it epidemiologically. Clostridium perfringens type C produces hemorrhagic enteritis in neonatal piglets with somewhat different clinical and pathological features. Salmonellosis can cause enteric disease with systemic illness in various age groups. Swine dysentery affects primarily the large intestine with different fecal characteristics. Appropriate diagnostic testing is essential to establish accurate diagnosis given the different management implications of various enteric pathogens.

Complications and sequelae of PEDV infection extend beyond the acute disease phase and contribute to overall economic impact. Surviving piglets may suffer permanent intestinal damage affecting nutrient absorption and growth potential throughout their lives. Secondary bacterial infections including colibacillosis may complicate recovery in PEDV-damaged intestines. Sow reproductive performance may be temporarily compromised by illness, affecting subsequent farrowing productivity. Immunosuppression during acute infection may increase susceptibility to other diseases. Persistence of viral shedding can complicate elimination efforts. Herd immunity dynamics following outbreak may leave windows of vulnerability as maternal antibody wanes in subsequent pig crops. Understanding these potential complications informs realistic expectations for recovery and guides long-term management planning.